Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease

By Alexandre Bejanin, D. Schonhaut, R. La Joie, Joel H. Kramer, Suzanne L. Baker, N. Sosa, Nagehan Ayakta, Averill Cantwell, Mustafa Janabi, Mariella Lauriola and 7 more. Brain : a journal of neurology, 2017

688 citations recorded by the source corpus.

Subfields: Cognitive Neuroscience, Physiology, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/0d7e1a71b07963f18908a3f61ccecbba6b2f1d57

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. F. Kametani
2. M. Hasegawa

Citations in the corpus

• Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease (2018, background): “Recent PET studies have shown that the spatial patterns of tau tracer binding are closely linked to the patterns of neurodegeneration and the clinical presentation in AD patients (Bejanin et al., 2017; Okamura and Yanai, 2017) and that subjective cognitive decline is indicative of early tauopathy in”